IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events
2024
- Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by
Maury Raycroft , Ph.D.Equity Research Analyst, Biotechnology
Goldman Sachs 45th Annual Global Healthcare Conference
- Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by
Corinne (Jenkins) Johnson , Vice President,Equity Research , Biotechnology
A live audio webcast of the conference events, as permitted by the conference host, will be available at the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of available webcasts will be accessible for 30 days following the live event.
About
IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's recent Annual Report on Form 10-K filed on
Investor and Media Contact
Senior Vice President, Head of Finance and Investor Relations
investor@ideayabio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-june-2024-investor-relations-events-302155550.html
SOURCE